# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $102 t...
RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Sector Perform and maintains $92 price target.
UBS analyst Matthew Taylor maintains Medtronic (NYSE:MDT) with a Sell and raises the price target from $75 to $76.
Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and lowers the price target from $90 t...
Needham analyst Mike Matson reiterates Medtronic (NYSE:MDT) with a Hold.
Strong earnings and revenue guidance from Nvidia sparked a tech stock surge, with Nasdaq 100 and S&P 500 hitting record highs.
Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0...
Major U.S.